Compugen Ltd. announced the appointment of Michele Holcomb, Ph.D., as a new independent director to its Board of Directors, effective February 11, 2026. Dr. Holcomb brings over 30 years of experience in biotech, pharmaceuticals, and healthcare services, including executive roles at Cardinal Health and Teva Pharmaceuticals.
Key takeaways
Appointment of Michele Holcomb, Ph.D., as independent director effective February 11, 2026
Dr. Holcomb previously served as EVP, Chief Strategy and Business Development Officer at Cardinal Health
Dr. Holcomb was Chief Operating Officer of Global R&D and SVP of Strategy at Teva Pharmaceuticals
Dr. Holcomb serves on boards of PureTech Health plc, Kimball Electronics, Inc., and Controlant hf
Compugen described as clinical-stage cancer immunotherapy company with AI/ML-powered discovery platform